Scientific due diligence
We read the primary literature, interrogate the protocol and separate what has been demonstrated from what has been inferred.
Technology and biotechnology translation
From ambitious science to practical advances.
Exothropic partners with researchers and companies to move emerging technology and biotechnology out of the lab and into the world.
- 04
- Focus areas
- 05
- Readiness levels
- 04
- Stage process
- 01
- Standard: evidence
What Exothropic offers
Venture building
Where the evidence holds, we help form the company: technical leadership, licence terms, development plan and first funding.
Development partnerships
For groups with the science but not the capacity, we structure joint programmes with clear decision gates and shared milestones.
Commercial pathways
Qualification, supply and unit economics are treated as engineering problems from the first week, not questions deferred to later.
Interactive · demo
Focus area explorer
Four areas where translation, rather than discovery, is usually the limiting step. Each includes a short thesis, example problem statements and an indicative translation readiness level. The problem statements and readiness levels are illustrative samples written for this demonstration.
Biotechnology thesis
Biology is becoming an engineering discipline, but the bottleneck has moved from discovery to reproducibility and scale. We look for work where a measurable biological result can survive a change of operator, reagent lot and facility — because that is the point at which a partner can commit capital to it.
Example problem statements
- 01
A strain engineered for a high-value precursor loses two-thirds of its titre when moved from shake flasks to a 50 L fermenter.
- 02
An assay with excellent published sensitivity has no defined sample-handling protocol, so results drift between collaborating sites.
- 03
A cell-free manufacturing route is elegant at microlitre scale but its enzyme cost per gram has never been costed against the incumbent process.
Translation readiness
Hover or tap a level to read what it meansLevel 3 — Reproduced
The result has been repeated by a second team or on second-source equipment, with the protocol written down.
Estimated typical level for this area: 3 of 5. Typical across the biotechnology work we see: strong bench results, protocols still being hardened. This is an internal framing tool, not an industry standard.
What we do
Translation is a discipline, not a hand-off.
Most promising science does not fail because the idea was wrong. It fails because nobody owned the unglamorous work between a result and a product: reproducing it, costing it, sourcing it, qualifying it. Exothropic is designed around owning that work alongside the people who did the science.
Example scenarios
Illustrative situations written to show how the model would apply. They do not describe real clients or engagements.
A university group with a reproduced result
A materials group has an abrasion-resistant coating that a second laboratory has now replicated. They need a qualification plan and an industrial partner rather than another grant.
A corporate innovation team scanning externally
An industrial group wants a defensible view on whether a class of biological manufacturing routes is worth an internal programme, and where the credible teams are.
A deep tech investor with a technical question
An investor has a term sheet drafted and needs someone to test the one claim the whole thesis rests on before signing.
How we work
Four stages, each with a decision at the end of it.
Every stage is designed to be stoppable. Expand a stage to see what happens inside it and what has to be true before the next one starts. Durations are indicative.
- We read the primary work, speak with the group that produced it and map what is genuinely known against what is assumed. The output is a plain-language description of the result, the conditions it depends on and the questions that would change our view. Where a technology is not ready, we say so and explain what would make it ready.
Indicative duration: 2–4 weeks
About the name
Why “Exothropic”?
Exothropic is a coined, science-styled name rather than an established scientific term. It is built to sound as though it belongs in a research setting while carrying no existing technical definition — a deliberate choice for a company whose work spans several fields.
The exo- element reads as outward, beyond, external: exoskeleton, exoplanet, exothermic. The -thropic ending gives it the cadence of a scientific adjective, the way phototropic or allotropic do. Together they suggest a turn outward — exploration past the edge of what is currently established, which is exactly where translation work happens.
Practically, a coined name is easier to own. It is distinctive, unlikely to collide with existing terminology, and it does not pin the brand to a single technology as a descriptive name would.
- exo-
- outward, beyond, external
- -throp-
- a turn, a direction taken
- -ic
- of that kind or nature
FAQ
Questions we would expect
Straight answers about how the model is meant to work, and about what this site is.
Contact
Propose a project
Tell us what you have demonstrated, under what conditions, and what you think the next decision is. Short and specific is better than polished.
Who this is for
- Researchers with a result that has left the first laboratory
- University tech transfer offices scoping a licence
- Deep tech investors testing a single technical claim
- Corporate innovation teams surveying a field
This form is part of a concept demonstration and does not send anything. For real enquiries, email info@exergist.com.